from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1941/-

LFCtreatmentdescriptionclass of inhibitor

-0.319

Amikacinug/mL Amikacintranslation

-0.286

Cap5-10ug/mL Capreomycintranslation

-1.235

Rox10-50 ug/mL Roxithromycintranslation

-0.209

SM2-5 ug/mL Streptomycintranslation

-1.856

Tet5-10 ug/mL Tetracyclinetranslation

0.716

Rif0.2-5ug/mL Rifampicintranscription

0.494

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.357

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.176

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.594

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.044

Clofazimine10-13 ug/mL Clofaziminerespiration

-1.109

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.386

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.127

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.966

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.113

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.951

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.011

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.302

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.980

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.594

KCN5-20 ug/mL Potassium cyaniderespiration

1.245

NaN30.2-2 mM Sodium aziderespiration

0.335

Nigericin50 uM Nigericinrespiration

-0.180

TRC10-150 ug/mL Triclosanrespiration

0.184

TRZ10-25 ug/mL Thioridazinerespiration

-0.367

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.271

menadione6-10 ug/mL Menadionerespiration

-0.127

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.540

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.003

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.271

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.824

NRP_1Non-replicating persistence stage 1dosRassociated

0.212

Amp0.2mg/mL AmpicillincellWall

-0.173

Cephalexin20-100 ug/mL CephalexincellWall

0.714

Cerulenin0.32-5 ug/mL CerulenincellWall

0.483

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.294

EMB10-20 ug/mL EthambutolcellWall

0.204

Eta12-40 ug/mL EthionamidecellWall

0.413

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.100

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.699

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.694

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

BZA0.12 mg/mL BenzamidearomaticAmides

0.000

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.000

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.000

H2O24 mM hydrogen peroxideDNAdamaging

-0.096

Levo10 ug/mL LevofloxacinDNAdamaging

0.000

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.015

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.056

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.000

UVUV-irradiationDNAdamaging

-0.368

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.307

Antimycin12.5-50 ug/mL Antimycin A?

-0.157

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-1.281

PA_110-50 ug/mL Antitubercular compound PA-1?

0.407

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.774

PA8240.2-2 ug/mL PA-824?

0.401

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.162

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.520

Verapamil50 uM Verapamil?

-0.243

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.471

methoxatin10-20 ug/mL Methoxatin?